Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
ERAS
#1240
Erasca, Inc. Common Stock
18.2
3
USD
+2.13%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+2.13%
Changement Mensuel
+28.83%
Evolution sur 6 mois
+603.86%
Changement Annuel
+1444.92%
Clôture Précédente
17.8
5
Open
17.9
1
Bid
Ask
Low
17.8
8
High
18.6
1
Volume
553
Marchés
Actions des Marchés US
Soins de Santé
ERAS
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
121.59 M
150.59 M
151.49 M
283.27 M
310.8 M
—
Valuation ratios
Enterprise value
1.53 B
357.29 M
235.67 M
643.26 M
1.08 B
2.24 B
Price to earnings ratio
—
-2.14
-2.61
-3.64
-8.45
-19.48
Price to sales ratio
—
—
—
455.65
361.71
882.89
Price to cash flow ratio
—
-5.03
-3.22
-5.36
-11.05
-23.65
Price to book ratio
—
1.26
1.03
1.39
3.24
4.03
Enterprise value to EBITDA ratio
—
—
—
-3.69
-8.02
-15.95
Profitability ratios
Return on assets %
-0.24
-0.47
-0.32
-0.32
-0.31
-0.29
Return on equity %
-0.27
-0.59
-0.39
-0.38
-0.38
-0.35
Return on invested capital %
-526.04
-1 096.55
-652.79
-476.63
-332.82
-361.15
Gross margin %
—
—
—
100
100
400
Operating margin %
—
—
—
-13.94 K
-4 832.13
-19.36 K
EBITDA margin %
—
—
—
-13.55 K
-4 625.58
-18.53 K
Net margin %
—
—
—
-12.55 K
-4 271.12
-17.11 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
15.92
9.13
12.26
9.84
10.04
43.87
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
0
0.01
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-0.85
-0.67
-0.47
-0.34
-0.34
EBIT per share
—
—
—
-0.76
-0.49
-0.49
EBITDA per share
—
—
—
-0.75
-0.48
-0.48
Total debt per share
—
—
—
—
—
—
Cash per share
—
3.57
2.08
1.28
1.21
4.92
Net current asset value per share
—
3.64
2.14
1.32
1.01
4.27
Tangible book value per share
—
3.38
2.11
1.81
1.15
5.1
Working capital per share
—
3.24
1.96
1.19
0.91
3.88
Book value per share
—
3.38
2.11
1.81
1.15
5.1
Nouvelles
Jefferies réitère sa recommandation d’achat sur Erasca malgré les données d’un essai concurrent
L’action Erasca Inc atteint un sommet de 52 semaines à 16,41 $
Opinion: These charts suggest the bears aren’t done with the stock market yet
Stifel réitère sa recommandation d’achat sur Erasca, objectif 20$
Stifel reiterates Buy rating on Erasca stock, $20 target
H.C. Wainwright relève l’objectif de cours d’Erasca à 20$
Erasca stock price target raised to $20 by H.C. Wainwright on trial data
Opinion: The S&P 500 just broke a major support. Another 10% decline is likely.
Stifel relève l’objectif de cours d’Erasca à 20$ sur fond d’expansion en Chine
Stifel raises Erasca stock price target to $20 on China expansion
Erasca obtient les droits mondiaux sur le médicament anti-RAS ERAS-0015
Erasca secures worldwide rights to RAS-targeting drug ERAS-0015